$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

$psbd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038473 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$14.20M	$13.59M	$8.671M
YoY Change	48.7%	56.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$13.50M	$12.83M	$5.867M
YoY Change	86.88%	118.73%
Operating Profit	-$13.24M	-$12.59M	-$5.584M
YoY Change	90.59%	125.5%
Interest Expense		$10.32M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$23.94M	$28.09M	-$3.431M
YoY Change	-136.64%	-918.71%
Net Earnings / Revenue	168.59%	206.64%	-39.57%
Basic Earnings Per Share	$0.94	$1.14	-$0.15
Diluted Earnings Per Share	$0.94	$1.14	-$0.15
COMMON SHARES
Basic Shares Outstanding	25.04M shares	24.41M shares	22.81M shares
Diluted Shares Outstanding	25.45M shares	24.59M shares	22.81M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$6.737M	$6.242M	$4.737M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.082B	$1.060B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$655.1M	$657.6M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$25.77K	$24.98K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$426.5M	$402.6M	$454.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.082B	$1.060B
YoY Change

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$23.94M	$28.09M	-$3.431M
YoY Change	-136.64%	-918.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		$27.95M	-$8.306M
YoY Change		-436.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$23.35M	$11.95M
YoY Change		-295.45%
NET CHANGE
Cash From Operating Activities		$27.95M	-$8.306M
Cash From Investing Activities
Cash From Financing Activities		-$23.35M	$11.95M
Net Change In Cash		$4.591M	$3.643M
YoY Change		26.03%
FREE CASH FLOW
Cash From Operating Activities		$27.95M	-$8.306M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24591581	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56126
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Palmer Square Capital BDC Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3665200
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1900 Shawnee Mission Parkway
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 315
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Mission Woods
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	66205
CY2023Q1	dei	City Area Code CityAreaCode	(816)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	994-3200
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25043540	shares
CY2022Q4	us-gaap	Assets Assets	1057453028	usd
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1130719129	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1120099935	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1042644015	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1017211732	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6242191	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1650801	usd
CY2023Q1	cik0001794776	Receivable For Sales Of Investments ReceivableForSalesOfInvestments	4041576	usd
CY2022Q4	cik0001794776	Receivable For Sales Of Investments ReceivableForSalesOfInvestments	31014356	usd
CY2023Q1	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	242872	usd
CY2022Q4	cik0001794776	Receivable For Paydowns Of Investments ReceivableForPaydownsOfInvestments	136119	usd
CY2023Q1	cik0001794776	Due From Affiliates Current DueFromAffiliatesCurrent	239028	usd
CY2022Q4	cik0001794776	Due From Affiliates Current DueFromAffiliatesCurrent	234102	usd
CY2023Q1	us-gaap	Dividends Receivable DividendsReceivable	217698	usd
CY2022Q4	us-gaap	Dividends Receivable DividendsReceivable	141997	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	6020267	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	6465594	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	604026	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	598327	usd
CY2023Q1	us-gaap	Assets Assets	1060251673	usd
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	2257962	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	211994	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	616414365	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	641309417	usd
CY2023Q1	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	38167495	usd
CY2022Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	42750748	usd
CY2022Q4	us-gaap	Distribution Payable DistributionPayable	6941066	usd
CY2023Q1	cik0001794776	Directors Fees Payable DirectorsFeesPayable	1912228	usd
CY2022Q4	cik0001794776	Directors Fees Payable DirectorsFeesPayable	1872815	usd
CY2023Q1	cik0001794776	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	1121556	usd
CY2022Q4	cik0001794776	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	1135500	usd
CY2023Q1	us-gaap	Liabilities Liabilities	657615644	usd
CY2022Q4	us-gaap	Liabilities Liabilities	694009546	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24975302	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24975302	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24286628	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24286628	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	24975	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24287	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	485024914	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	473921377	usd
CY2023Q1	cik0001794776	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	-82413860	usd
CY2022Q4	cik0001794776	Investment Company Distributable Earning InvestmentCompanyDistributableEarning	-110502182	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	402636029	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1060251673	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1057453028	usd
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.12
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.96
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	25452738	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	14157273	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	676868	usd
CY2022Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	4646	usd
CY2023Q1	us-gaap	Other Income OtherIncome	55896	usd
CY2022Q1	us-gaap	Other Income OtherIncome	93041	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	26185502	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	14254960	usd
CY2023Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	26185502	usd
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	14254960	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	10322130	usd
CY2022Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	3151012	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1912228	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	138440	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18493	usd
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	18493	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	367006	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	300725	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12831851	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5866632	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-369870	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	239028	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	282245	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12592823	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5584387	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	13592679	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	8670573	usd
CY2023Q1	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-317446	usd
CY2022Q1	cik0001794776	Non Affiliate Non Control Investments NonAffiliateNonControlInvestments	-369870	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-369870	usd
CY2023Q1	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	-14813089	usd
CY2022Q1	cik0001794776	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	11731503	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11731503	usd
CY2023Q1	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	14495643	usd
CY2022Q1	cik0001794776	Net Realized And Unrealized Gainloss On Investments NetRealizedAndUnrealizedGainlossOnInvestments	-12101373	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	28088322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3430800	usd
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.55
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.38
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.14
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24591581	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22807768	shares
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	13592679	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	8670573	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-317446	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-369870	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11731503	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	28088322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3430800	usd
CY2023Q1	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock	-11104225	usd
CY2022Q1	cik0001794776	Issuance Of Common Stock IssuanceOfCommonStock	-4823800	usd
CY2023Q1	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	11104225	usd
CY2022Q1	cik0001794776	Net Increase In Net Assets From Capital Share Transactions NetIncreaseInNetAssetsFromCapitalShareTransactions	4823800	usd
CY2023Q1	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	39192547	usd
CY2022Q1	cik0001794776	Total Increase Decrease In Net Assets TotalIncreaseDecreaseInNetAssets	1393000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	363443482	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	452797588	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	402636029	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	454190588	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	28088322	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-3430800	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	14813089	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11731503	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	352426	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	111281	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	230510615	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6242191	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4736739	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7944419	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	3484766	usd
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	137515526	usd
CY2023Q1	cik0001794776	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	63457688	usd
CY2022Q1	cik0001794776	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	158946166	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	181245181	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	168868099	usd
CY2023Q1	cik0001794776	Proceeds From Sale Of Portfolio Investments ProceedsFromSaleOfPortfolioInvestments	102138907	usd
CY2022Q1	cik0001794776	Proceeds From Sale Of Portfolio Investments ProceedsFromSaleOfPortfolioInvestments	147465895	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	244963	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	243676	usd
CY2023Q1	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	-26972780	usd
CY2022Q1	cik0001794776	Increasedecrease In Receivable For Sales Of Investments IncreasedecreaseInReceivableForSalesOfInvestments	12674429	usd
CY2023Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-369626	usd
CY2022Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	413399	usd
CY2023Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	4926	usd
CY2022Q1	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	1505	usd
CY2023Q1	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	106753	usd
CY2022Q1	cik0001794776	Increasedecrease In Receivable For Paydowns Of Investments IncreasedecreaseInReceivableForPaydownsOfInvestments	69718	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5699	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	165494	usd
CY2023Q1	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	-2377711	usd
CY2022Q1	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	333754	usd
CY2023Q1	cik0001794776	Increasedecrease In Payable For Investments Purchased IncreasedecreaseInPayableForInvestmentsPurchased	4583253	usd
CY2022Q1	cik0001794776	Increasedecrease In Payable For Investments Purchased IncreasedecreaseInPayableForInvestmentsPurchased	21726598	usd
CY2023Q1	cik0001794776	Increasedecrease In Management Fees Payable IncreasedecreaseInManagementFeesPayable	-39413	usd
CY2022Q1	cik0001794776	Increasedecrease In Management Fees Payable IncreasedecreaseInManagementFeesPayable	-12044	usd
CY2022Q1	cik0001794776	Increasedecrease In Directors Fee Payable IncreasedecreaseInDirectorsFeePayable	617	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-13943	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1607683	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27945957	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8305883	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	33000000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	27500000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	17726	usd
CY2023Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	6941066	usd
CY2022Q1	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	5874681	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11104225	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4823800	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23354567	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11949119	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4591390	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3643236	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1650801	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1093503	usd
CY2023Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	1.50	pure
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q1	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Indemnifications</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	100000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2400000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2500000	usd
CY2022Q4	cik0001794776	Consolidated Statements Of Assets And Liabilities ConsolidatedStatementsOfAssetsAndLiabilities	641300000	usd
CY2023Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	2600000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2200000	usd
CY2023Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	4800000	usd
CY2023Q1	cik0001794776	Consolidated Statements Of Assets And Liabilities ConsolidatedStatementsOfAssetsAndLiabilities	616400000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.90	pure
CY2022Q4	us-gaap	Investments Investments	1017211732	usd
CY2023Q1	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.02	pure
CY2023Q1	us-gaap	Management Fee Description ManagementFeeDescription	The Investment Advisor, however, has agreed to waive its right to receive management fees in excess of 1.75% of the total net assets during any period prior to the listing of the Company’s common stock on a national securities exchange (a “Listing”).
CY2023Q1	us-gaap	Incentive Fee Description IncentiveFeeDescription	The Company will pay the Investment Advisor an Income Incentive Fee with respect to its “adjusted net investment income” in each calendar quarter as follows: ● no Income Incentive Fee in any calendar quarter in which the Company’s “adjusted net investment income” does not exceed an amount equal to a “hurdle rate” of 1.5% per quarter (6% annualized) of the Company’s total net assets at the end of that quarter (the “Hurdle Amount”); ● 100% of the Company’s “adjusted net investment income” with respect to that portion of such “adjusted net investment income,” if any, that exceeds the Hurdle Amount but is less than or equal to an amount (the “Catch-Up Amount”) determined on a quarterly basis by multiplying 1.6875% by the Company’s total net asset value for the immediately preceding calendar quarter. The Catch-Up Amount is intended to provide the Investment Advisor with an incentive fee of 12.5% on all of the Company’s “adjusted net investment income” when the Company’s “adjusted net investment income” reaches the Catch-Up Amount in any calendar quarter; and ● for any calendar quarter in which the Company’s “adjusted net investment income” exceeds the Catch-Up Amount, the Income Incentive Fee shall equal 12.5% of the amount of the Company’s “adjusted net investment income” for the calendar quarter.
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1130719129	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1042644015	usd
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1120099935	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1017211732	usd
CY2023Q1	cik0001794776	Longterm Investment Portfolio Percentage LongtermInvestmentPortfolioPercentage	0.153	pure
CY2023Q1	cik0001794776	Amortized Cost Rate AmortizedCostRate	0.155	pure
CY2022	cik0001794776	Longterm Investment Portfolio Percentage LongtermInvestmentPortfolioPercentage	0.16	pure
CY2022	cik0001794776	Amortized Cost Rate AmortizedCostRate	0.163	pure
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.138	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.149	pure
CY2023Q1	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2022Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage	1	pure
CY2023Q1	us-gaap	Investments Investments	1042644015	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24591581	shares
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	1.65	pure
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1217000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	2697000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	(2)The carrying value of the WF Credit Facility is presented net of deferred financing costs of $1.047 million and accrued interest of $1.880 million.
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	688674	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	11100000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	240396	shares
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	4800000	usd
CY2023Q1	cik0001794776	Unfunded Commitments UnfundedCommitments	667000	usd
CY2022	cik0001794776	Unfunded Commitments UnfundedCommitments	2600000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	666600000000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	2636943000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	28088322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3430800	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22807768	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q4	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	14.96
CY2021Q4	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	20.06
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.55
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.38
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0.61	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-0.53	usd
CY2023Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.16
CY2022Q1	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	-0.15
CY2023Q1	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	16.12
CY2022Q1	cik0001794776	Net Assets Value Per Share NetAssetsValuePerShare	19.91
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	24975302	shares
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	22810727	shares
CY2023Q1	us-gaap	Assets Net AssetsNet	402636029	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	454190588	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24591581	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22807768	shares
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0775	pure
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0075	pure
CY2023Q1	cik0001794776	Portfolio Turnover PortfolioTurnover	0.07	pure
CY2022Q1	cik0001794776	Portfolio Turnover PortfolioTurnover	0.13	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.1342	pure
CY2022Q1	us-gaap	Investment Company Expense Ratio Voluntary Fee Waiver InvestmentCompanyExpenseRatioVoluntaryFeeWaiver	0.052	pure
CY2023Q1	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.1317	pure
CY2022Q1	us-gaap	Investment Company Expense Ratio Including Voluntary Fee Waiver InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver	0.0495	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.1397	pure
CY2022Q1	us-gaap	Investment Company Investment Income Loss Ratio Before Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation	0.0743	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.1422	pure
CY2022Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0768	pure
CY2023Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	68238	shares
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1100000	usd
CY2023Q2	cik0001794776	Common Stock Sold CommonStockSold	5100000	usd
CY2023Q1	cik0001794776	Increasedecrease In Directors Fee Payable IncreasedecreaseInDirectorsFeePayable		usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2022Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22807768	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001794776

Files In Submission

Name	View Source	Status
cik0001794776-20230331_pre.xml	Edgar Link	unprocessable
cik0001794776-20230331_def.xml	Edgar Link	unprocessable
0001213900-23-038473-index-headers.html	Edgar Link	pending
0001213900-23-038473-index.html	Edgar Link	pending
0001213900-23-038473.txt	Edgar Link	pending
0001213900-23-038473-xbrl.zip	Edgar Link	pending
cik0001794776-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_palmersquare.htm	Edgar Link	pending
f10q0323ex31-2_palmersquare.htm	Edgar Link	pending
f10q0323ex32-1_palmersquare.htm	Edgar Link	pending
f10q0323ex32-2_palmersquare.htm	Edgar Link	pending
f10q0323_palmersquare.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_palmersquare_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cik0001794776-20230331_cal.xml	Edgar Link	unprocessable
cik0001794776-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd

2023 Q2 Form 10-Q Financial Statement

#000121390023038473 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD Palmer Square Capital BDC Inc. Stock $psbd

2023 Q2 Form 10-Q Financial Statement

#000121390023038473 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PSBD
Palmer Square Capital BDC Inc. Stock $psbd